Sign in
Key:
Free Content - Free content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Journal of Pharmacy and Pharmacology logo

Volume 56, Number 8, 1 August 2004

< previous issue | next issue > | all issues

Research Papers: Pharmaceutics and Drug Delivery

A comparison of topical formulations for the prevention of human schistosomiasis
pp. 957-962(6)
Authors: E. Cooper; A. Iqbal; A. Bartlett; C. Marriott; P.J. Whitfield; M.B. Brown

Research Papers: Biopharmaceutics and Drug Disposition

Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomes
pp. 963-966(4)
Authors: Kiran C. Patki; David J. Greenblatt; Lisa L. von Moltke

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds – implications for pharmacokinetics of selected substrates
pp. 967-975(9)
Authors: Amal Abou El Ela; Sebastian Härtter; Ulrich Schmitt; Christoph Hiemke; Hildegard Spahn-Langguth; Peter Langguth

Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells
pp. 1001-1005(5)
Authors: Shuji Kitagawa; Tomohiro Nabekura; Shizu Kamiyama

Inhibition of in-vitro simvastatin metabolism in rat liver microsomes by bergamottin, a component of grapefruit juice
pp. 1007-1014(8)
Authors: N. Le Goff-Klein; L. Klein; M. Hérin; J.-C. Koffel; G. Ubeaud

Research Papers: Molecular and Clinical Pharmacology

Research Papers: Biomedicinal Chemistry

Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents
pp. 1029-1037(9)
Authors: Nicolas Gouault; Corinne A.E. Martin-Chouly; Claire Lugnier; Jean-François Cupif; Amaury Tonnelier; Frédéric Feger; Vincent Lagente; Michèle David

Research Papers: Drugs from Natural Sources

Inhibition of human cytochromes P450 by components of Ginkgo biloba
pp. 1039-1044(6)
Authors: Lisa L. von Moltke; James L. Weemhoff; Erdal Bedir; Ikhlas A. Khan; Jerold S. Harmatz; Peter Goldman; David J. Greenblatt

Communications

Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations
pp. 1055-1059(5)
Authors: Fumio Itagaki; Masato Homma; Kenji Yuzawa; Masuhiro Nishimura; Shinsaku Naito; Nobuhiko Ueda; Nobuhiro Ohkohchi; Yukinao Kohda

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318
pp. 1061-1066(6)
Authors: Li-ming Chen; Yong-ju Liang; Ji-wu Ruan; Yan Ding; Xiu-wen Wang; Zhi Shi; Lian-Quan Gu; Xiao-ping Yang; Li-wu Fu

< previous issue | next issue > | all issues

Top 
© Pharmaceutical Press 2006
Accessibility | Terms and Conditions